Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study

BACKGROUND: Glutamine (Gln) may become conditionally indispensable during critical illness. The short-term metabolic effects of enteral versus parenteral Gln supplementation are unknown in this clinical setting. OBJECTIVES: We studied metabolic effects of intravenous (IV) alanyl-Gln dipeptide (AG) s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Luo, Menghua, Bazargan, Niloofar, Griffith, Daniel P., Fernández-Estívariz, Concepción, Leader, Lorraine M., Easley, Kirk A., Daignault, Nicole M., Hao, Li, Meddings, Jon B., Galloway, John R., Blumberg, Jeffrey B., Jones, Dean P., Ziegler, Thomas R.
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2692723/
https://ncbi.nlm.nih.gov/pubmed/18258342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clnu.2007.12.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares